XML 21 R7.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF CHANGES IN TOTAL EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Shares
Capital in Excess of Stated Value
Accumulated Other Comprehensive Loss
Retained Earnings
Non- controlling Interests
Beginning balance at Dec. 31, 2021 $ 1,849,541 $ 7,175 $ 119,690 $ (359,425) $ 2,070,005 $ 12,096
Beginning Balance (in shares) at Dec. 31, 2021   97,370        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income/(loss) 466,980       466,437 543
Other comprehensive (loss)/income            
Translation (loss)/income (68,780)     (69,240)   460
Defined benefit plan adjustment [1] 424     424    
Derivative financial instruments [1] (1,842)     (1,842)    
Other comprehensive (loss)/income (70,198)     (70,658)   460
Purchase of noncontrolling interest (13,196)   (7,080)     (6,116)
Dividends (188,259)       (188,259)  
Issuance of stock awards 1,167   1,167      
Issuance of stock awards (in shares)   354        
Shares repurchased (4,547)   (4,547)      
Shares repurchased (in shares)   (79)        
Share-based compensation 31,309   31,309      
Ending balance at Dec. 31, 2022 2,072,797 $ 7,175 140,539 (430,083) 2,348,183 6,983
Ending Balance (in shares) at Dec. 31, 2022   97,645        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income/(loss) 475,901       474,959 942
Other comprehensive (loss)/income            
Translation (loss)/income 70,308     70,738   (430)
Defined benefit plan adjustment [1] (8,654)     (8,654)    
Derivative financial instruments [1] 1,737     1,737    
Other comprehensive (loss)/income 63,391     63,821   (430)
Dividends (198,762)       (198,762)  
Issuance of stock awards 1,345   1,345      
Issuance of stock awards (in shares)   488        
Shares repurchased (10,617)   (10,617)      
Shares repurchased (in shares)   (176)        
Share-based compensation 27,780   27,780      
Ending balance at Dec. 31, 2023 $ 2,431,835 $ 7,175 159,047 (366,262) 2,624,380 7,495
Ending Balance (in shares) at Dec. 31, 2023 97,957 97,957        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income/(loss) $ 163,940       163,949 (9)
Other comprehensive (loss)/income            
Translation (loss)/income (143,730)     (143,353)   (377)
Defined benefit plan adjustment [1] 9,014     9,014    
Derivative financial instruments [1] (2,133)     (2,133)    
Other comprehensive (loss)/income (136,849)     (136,472)   (377)
Divestiture of non-controlling interest 2,043         2,043
Non-controlling interest from acquisition 9,533         9,533
Dividends (204,406)       (204,406)  
Issuance of stock awards 915   915      
Issuance of stock awards (in shares)   467        
Shares repurchased (9,246)   (9,246)      
Shares repurchased (in shares)   (164)        
Share-based compensation 29,659   29,659      
Other 2,875   2,875      
Ending balance at Dec. 31, 2024 $ 2,286,213 $ 7,175 $ 183,250 $ (502,734) $ 2,583,923 $ 14,599
Ending Balance (in shares) at Dec. 31, 2024 98,260 98,260        
[1] net of tax